Prognostic significance of renal function in patients undergoing dobutamine stress echocardiography

Nephrology Dialysis Transplantation

Volumn 23, Issue 2, 2008, Pages 601-607

  Karagiannis, Stefanos E ^a   Feringa, Harm H H ^a   Elhendy, Abdou ^b   Van Domburg, Ron ^a   Chonchol, Michel ^c   Vidakovic, Radosav ^a   Bax, Jeroen J ^d   Karatasakis, George ^e   Athanasopoulos, George ^e   Cokkinos, Dennis V ^e   Poldermans, Don ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MARSHFIELD CLINIC   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d LEIDEN UNIVERSITY   (Netherlands)

^e ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

Dobutamine stress echocardiography; Prognosis; Renal function

Indexed keywords

CREATININE; DOBUTAMINE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; EXERCISE ELECTROCARDIOGRAPHY; FEMALE; HEART DEATH; HEMODYNAMICS; HUMAN; KAPLAN MEIER METHOD; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS;

AGED; DOBUTAMINE; ECHOCARDIOGRAPHY, STRESS; FEMALE; HEART DISEASES; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PROGNOSIS;

EID: 44449104142     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm642     Document Type: Article

References (21)

1. Sarnak MJ, Levey AS, Schoolwerth AC et al. A statement from American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Kidney disease as a risk factor for development of cardiovascular disease. Circulation 2003; 108: 2154-2169
2. Hostetter TH. Chronic kidney disease predicts cardiovascular disease. N Engl J Med 2004; 351: 1344-1346
3. Baigent C, Burbury K, Wheeler D. Premature cardiovascular disease in chronic renal failure. Lancet 2000; 356: 147-152
4. Marwick TH, Lauer MS, Lobo A et al. Use of dobutamine echocardiography for risk stratification of patients with chronic renal failure. J Intern Med 1998; 244: 155-161
5. Sicari R, Pasanisi E, Venneri L, Landi P et al. Echo Persantine International Cooperative (EPIC) Study Group; Echo Dobutamine International Cooperative (EDIC) Study Group. Stress echo results predict mortality: a large-scale multicenter prospective international study. J Am Coll Cardiol 2003; 41: 589-595
6. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-1197
7. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41
8. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G. National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. Ann Intern Med 2003; 139: 137-147
9. Armstrong WF, Pellikka PA, Ryan T et al. Stress echocardiography: recommendations for performance and interpretation of stress echocardiography. Stress Echocardiography Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 1998; 11: 97-104
10. Arnese M, Cornel JH, Salustri A et al. Prediction of improvement of regionalleft ventricular function after surgical revascularization: a comparison of low dose dobutamine echocardiography with 201Tl single-photon emission computed tomography. Circulation 1995; 91: 2748-2752
11. Fleiss JL. Statistical Methods for Rates and Proportions, . New York: Wiley, 1981
12. Cox DR. Regression models and life-tables. J Roy Stat Soc B 1972; 34: 187-202
13. Kasiske BL, Ramos EL, Gaston RS et al. The evaluation of renal transplant candidates: clinical practice guidelines. Patient Care and Education Committee of the American Society of Transplant Physicians. J Am Soc Nephrol 1995; 6: 1-34
14. Sharma R, Pellerin D, Gaze DC et al. Dobutamine stress echocardiography and the resting but not exercise electrocardiograph predict severe coronary artery disease in renal transplant candidates. Nephrol Dial Transplant 2005; 20: 2207-2214
15. Dussol B, Bonnet JL, Sampol J et al. Prognostic value of inducible myocardial ischemia in predicting cardiovascular events after renal transplantation. Kidney Int 2004; 66: 1633-1639
16. Ix JH, Shlipak MG, Liu HH et al. Association between renal insufficiency and inducible ischemia in patients with coronary artery disease: the heart and soul study. J Am Soc Nephrol 2003; 14(12): 3233-3238. Erratum in: J Am Soc Nephrol 2004; 5(2): 508
17. Rakhit DJ, Armstrong KA, Beller E et al.Risk stratification of patients with chronic kidney disease: results of screening strategies incorporating clinical risk scoring and dobutamine stress echocardiography. Am Heart J 2006; 152: 363-370
18. Fragasso G, Lu C, Dabrowski P et al. Comparison of stress/rest myocardial perfusion tomography, dypiridamole and dobutamine stress echocardiography for the detection of coronary disease in hypertensive patients with chest pain and positive exercise test. J Am Coll Cardiol 1999; 34: 441-447
19. Geleijnse ML, Vigna C, Kaszprak JD et al. Usefulness and limitations of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in patients with left bundle branch block. A multicentre study. Eur Heart J 2000; 21: 1666-1673
20. Brennan DC, Vedala G, Miller SB et al. Pretransplant dobutamine stress echocardiography is useful and cost effective in renal transplant candidates. Transplant Proc 1997; 29: 233-234
21. Bergeron S, Hillis G, Oh JK et al. Dobutamine stress echocardiography as a prognostic and diagnostic tool in patients with end stage renal failure. Circulation 2004; 110(suppl III): 511